<?xml version="1.0" encoding="UTF-8"?>
<ref id="B31-pharmaceutics-12-00388">
 <label>31.</label>
 <element-citation publication-type="web">
  <person-group person-group-type="author">
   <collab>World Health Organisation</collab>
  </person-group>
  <source>Annex 4 Guidelines on Viral Inactivation and Removal Procedures Intended to Assure the Viral Safety of Human Blood Plasma Products</source>
  <year>2004</year>
  <comment>Available online: 
   <ext-link ext-link-type="uri" xlink:href="https://www.who.int/bloodproducts/publications/WHO_TRS_924_A4.pdf" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.who.int/bloodproducts/publications/WHO_TRS_924_A4.pdf</ext-link>
  </comment>
  <date-in-citation content-type="access-date" iso-8601-date="2020-04-24">(accessed on 24 April 2020)</date-in-citation>
 </element-citation>
</ref>
